Navigation Links
November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments
Date:11/13/2009

ife. The November issue of Mayo Clinic Health Letter provides an overview of treatments recommended by national guidelines.

Heart failure generally begins when heart muscle is damaged, from a heart attack or other factors such as high blood pressure, heavy alcohol use, diabetes, heart infection, faulty heart valves, heart rhythm problems or sleep apnea. Effective treatment can help slow or stop progression of heart failure.

Three classes of drugs, and sometimes a pacemaker or defibrillator device, can increase longevity. Medication categories are:

Angiotensin-converting enzyme (ACE) inhibitors: Medications in this category -- enalapril, lisinopril and others -- reduce production of angiotensin, a substance that causes blood vessels to narrow and blood pressure to rise. Lower blood pressure reduces workload on the heart.

Beta blockers: Drugs in this class -- metoprolol, bisoprolol and others -- slow the heart rate and lower blood pressure. Beta blockers are the single most effective drug at improving heart function and symptoms, possibly prolonging life for those with heart failure.

Aldosterone antagonists: This category, which includes spironolactone and eplerenone, removes sodium and water from the bloodstream. These drugs also block aldosterone, a hormone that can stress the heart.

For some patients, implanting a pacemaker to coordinate heartbeats can improve the heart's efficiency. Implantable cardioverter-defibrillators also may be recommended to detect and stop dangerous heart symptoms.

Studies have shown survival rates are 92 percent at two years for heart failure patients taking recommended medications from each category. Only 65 percent of patients who did nothing survived beyond two years.

Mayo Clinic Health Letter is an eight-page monthly newsletter of reliable, accurate and practical information on today's health and medical new
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
2. Barr Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8, 2007
3. Select Medical Corporation to Announce Third Quarter Results on Monday, November 12
4. Cardinal Health To Announce First-Quarter Results on November 5
5. Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park
6. US-Based Bollywood On-Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd
7. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
8. Health Fitness Corp. to Report Third Quarter 2007 Financial Results on November 5, 2007
9. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007
10. Jenny McCarthy Featured at National Autism Conference in Atlanta, November 9
11. Cynosure to Announce Third-Quarter 2007 Financial Results on November 1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Randy Dotinga HealthDay Reporter ... that causes malaria is growing increasingly resistant to the drugs ... But several new drugs are in development, and at least ... this global killer. "Although there has been considerable progress ... malaria is far from won, and there is still much ...
(Date:7/31/2014)... Recently, Agebc.com, a popular online shop of wedding dresses ... of trendy mother of the bride dresses . Aside ... now, up to 68% off. , “We are proud ... of mother of the bride dresses. We launch the special ... our online shop has received thousands of rave reviews from ...
(Date:7/31/2014)... New Delhi, India (PRWEB) July 31, 2014 ... Certified Internet Marketing Company, has introduced a new ... quite affordable.     , Ethane Web Technologies has designed ... the expectations of clients and Java Development service ... has given the company a confidence to promise ...
(Date:7/31/2014)... the dentist isn,t fun for anyone, but for those with ... discovery may have them smiling. In a report appearing in ... Leukocyte Biology , one of the most important blood ... shown to promote inflammation and bone loss in type 2 ... treatments that manipulate the responses of B cells may treat ...
(Date:7/31/2014)... Mirada, CA (PRWEB) July 31, 2014 ... leading healthcare providers, strives in maintaining the highest ... employers. That is why Healthpointe is offering ... to surrounding employers, employees and patients. They also ... insurance carriers. , Healthpointe’s Occupational Medicine services include, ...
Breaking Medicine News(10 mins):Health News:Malaria Growing Resistant to Drugs Used to Fight It 2Health News:Malaria Growing Resistant to Drugs Used to Fight It 3Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2
... VSCP ), a leading provider of quantitative ... the company,s chief executive,officer, will be presenting a corporate ... Conference at the Waldorf Astoria in New York City. ... at 3:45pm EST. , A ...
... finds all breaks, not just hip fractures, tied to increased ... fracture that occurs in people over age 60 needs to ... the Australian researchers found the risk of dying goes up ... for at least 10 years after a hip fracture. , ...
... former Senator Tom Daschle withdrew his name for consideration ... Human Services Department (HHS). From the beginning Senator ... for President Obama for a government takeover of our ... record while in the Senate, Family Research Council has ...
... Nearly three out of four Americans (71 ... cost of addiction treatment - yet most consumers ... would pay for substance abuse treatment, according to ... Hazelden, the national nonprofit organization that helps people ...
... until third year, study finds , , TUESDAY, Feb. ... period" for hormone replacement therapy has been identified ... that using estrogen-plus-progesterone therapy increases the risk for ... than taking estrogen alone. , The finding follows ...
... One-fifth of women who should receive radiation after a ... to a new study from researchers at the University ... at 396 women who were treated with a mastectomy ... of women who fell clearly within guidelines recommending radiation ...
Cached Medicine News:Health News:VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference 2Health News:Fractures in Older Adults Up Death Risk 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 3Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 4Health News:2 Years of Hormone Use May Be 'Safe' 2Health News:19 percent of breast cancer patients don’t receive recommended radiation after mastectomy 2
(Date:7/31/2014)... Quebec, July 31, 2014   , 2014 Second ... the prior year , Overall organic growth was 4% for ... injectable products; Bausch + Lomb grew 12% , 2014 ... of 43% , 2014 Second Quarter GAAP Operating Cash ... , Highlights of the Second Quarter , Launched 17 ...
(Date:7/31/2014)... 2014 Auxilium Pharmaceuticals, Inc. ... company, today announced that the Company will receive ... partner Asahi Kasei Pharma Corporation (Asahi Kasei). The ... of a regulatory application to the Japanese Pharmaceutical ... (collagenase clostridium histolyticum) for the treatment of ...
(Date:7/31/2014)... 2014 MarketResearchreports.biz presents this most ... (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And Modern and ... and Forecast (Value and Volume), 2013 - 2019: Market ... growing at an exponential rate worldwide, has become a ... major cause of death of people between 20 years ...
Breaking Medicine Technology:Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
... First Pro-Healing Stent Also ... Featured at Annual Symposium, ... the subject of several sessions about,innovation in interventional cardiology strategies ... 2007,which is set for Oct. 20-25 at the Washington Convention ...
... Bono Initiative Aims to Mobilize $25 Million to Eliminate ... Afflicting the Poorest of the Poor, EAST RUTHERFORD, N.J., ... nation,s top ten public relations firms, was,highlighted by President Bill ... for its key role in the fight against diseases of,poverty ...
Cached Medicine Technology:OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007 2President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 2President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 3President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 4
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... Remels newest member of the Xpect family, Xpect ... and B in one rapid test. The simple-to-perform ... available in 20 minutes. ,The Remel Xpect family ... range of rapid, direct specimen tests that combine ...
Inquire...
Inquire...
Medicine Products: